Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740909 · ClinicalTrials.gov registry record · Phase 1
Cognitive Behavioral Therapy for Trichotillomania
A Phase 1 study of Trichotillomania, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT00740909 is a Phase 1 study of Trichotillomania that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants, below the 67-participant average among 8 other Trichotillomania trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00740909, a Phase 1 study of Trichotillomania, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condition. We hypothesize that outcome at post-treatment, 3-month, and 6-month follow-up will be better for the CBT vs. MAC condition including higher responder rates and greater reduction in hair pulling severity.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00740909
The ClinicalTrials.gov registry entry for NCT00740909 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 8 other Trichotillomania trials with a reported enrollment target (43% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT00740909 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00740909 about?
NCT00740909 is a clinical study titled "Cognitive Behavioral Therapy for Trichotillomania". This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condi...
What is the current status of trial NCT00740909?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2008-11. Estimated completion is 2012-01.
What conditions does trial NCT00740909 study?
This clinical trial studies the following conditions: Trichotillomania.
What interventions are being tested in trial NCT00740909?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00740909?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00740909 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trichotillomania
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Technology Assisted Treatment of Trichotillomania: Open Trial
RECRUITING · NA
-
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
ACTIVE NOT RECRUITING · NA
-
N-Acetylcysteine for Pediatric Trichotillomania
COMPLETED · Phase 2
-
Cognitive Behavioral Treatment of Pediatric Trichotillomania
COMPLETED · NA
-
Response Inhibition Training for Individuals With Trichotillomania
COMPLETED · NA
-
A Study in Patients With Trichotillomania
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.